Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose Steroids in Children With Stroke and Unilateral Focal Arteriopathy
NCT03249844Phase 3Withdrawn
- Sponsor
- CHU Saint-Etienne
- Start
- Sep 2022
- Primary completion
- Dec 2027
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of methylprednisolone injection, prednisolone in arterial ischemic stroke (AIS), focal cerebral arteriopathy (FCA), sponsored by CHU Saint-Etienne. Planned start Sep 2022; status: withdrawn.
02
Drugs
methylprednisolone injectionprednisolone
03
Conditions
arterial ischemic stroke (AIS)focal cerebral arteriopathy (FCA)
Beyond the preview
Go deeper on NCT03249844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03249844.